Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 11 studies | 72% ± 13% | |
glutamatergic neuron | 9 studies | 39% ± 24% | |
type I pneumocyte | 7 studies | 27% ± 6% | |
GABAergic neuron | 7 studies | 38% ± 23% | |
endothelial cell | 6 studies | 31% ± 11% | |
oligodendrocyte | 6 studies | 21% ± 5% | |
neuron | 5 studies | 27% ± 8% | |
astrocyte | 5 studies | 24% ± 6% | |
oligodendrocyte precursor cell | 5 studies | 25% ± 8% | |
interneuron | 4 studies | 38% ± 21% | |
GABAergic interneuron | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 8807.71 | 653 / 653 | 99% | 52.28 | 599 / 605 |
brain | 100% | 7717.17 | 2642 / 2642 | 99% | 96.79 | 698 / 705 |
adrenal gland | 98% | 2750.82 | 254 / 258 | 93% | 49.86 | 213 / 230 |
prostate | 93% | 1611.29 | 228 / 245 | 97% | 32.46 | 488 / 502 |
kidney | 96% | 1929.35 | 85 / 89 | 93% | 33.57 | 840 / 901 |
breast | 96% | 1944.46 | 439 / 459 | 93% | 55.13 | 1039 / 1118 |
lung | 100% | 29592.26 | 577 / 578 | 70% | 65.74 | 810 / 1155 |
pancreas | 97% | 2384.91 | 319 / 328 | 54% | 10.18 | 96 / 178 |
ovary | 66% | 826.81 | 119 / 180 | 68% | 15.17 | 292 / 430 |
uterus | 87% | 1337.05 | 148 / 170 | 41% | 11.63 | 186 / 459 |
skin | 63% | 904.77 | 1141 / 1809 | 56% | 16.80 | 264 / 472 |
blood vessel | 98% | 2399.16 | 1313 / 1335 | 0% | 0 | 0 / 0 |
intestine | 79% | 1758.49 | 763 / 966 | 18% | 3.86 | 97 / 527 |
adipose | 95% | 1839.47 | 1139 / 1204 | 0% | 0 | 0 / 0 |
bladder | 71% | 1299.48 | 15 / 21 | 20% | 7.64 | 100 / 504 |
esophagus | 68% | 1684.55 | 979 / 1445 | 22% | 6.02 | 41 / 183 |
stomach | 64% | 1080.81 | 230 / 359 | 20% | 4.55 | 56 / 286 |
spleen | 81% | 963.81 | 196 / 241 | 0% | 0 | 0 / 0 |
heart | 76% | 1008.63 | 656 / 861 | 0% | 0 | 0 / 0 |
muscle | 75% | 1016.39 | 599 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 32.55 | 22 / 45 |
eye | 0% | 0 | 0 / 0 | 40% | 6.78 | 32 / 80 |
liver | 0% | 5.20 | 1 / 226 | 13% | 3.46 | 53 / 406 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.33 | 3 / 29 |
peripheral blood | 8% | 124.04 | 78 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070925 | Biological process | organelle assembly |
GO_0055091 | Biological process | phospholipid homeostasis |
GO_0030324 | Biological process | lung development |
GO_0006855 | Biological process | xenobiotic transmembrane transport |
GO_0015914 | Biological process | phospholipid transport |
GO_0032464 | Biological process | positive regulation of protein homooligomerization |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0150172 | Biological process | regulation of phosphatidylcholine metabolic process |
GO_0046890 | Biological process | regulation of lipid biosynthetic process |
GO_0006869 | Biological process | lipid transport |
GO_0042908 | Biological process | xenobiotic transport |
GO_2001140 | Biological process | positive regulation of phospholipid transport |
GO_0051384 | Biological process | response to glucocorticoid |
GO_1902995 | Biological process | positive regulation of phospholipid efflux |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0043129 | Biological process | surfactant homeostasis |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0019538 | Biological process | protein metabolic process |
GO_0034204 | Biological process | lipid translocation |
GO_0046618 | Biological process | xenobiotic export from cell |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0046471 | Biological process | phosphatidylglycerol metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0042599 | Cellular component | lamellar body |
GO_0097208 | Cellular component | alveolar lamellar body |
GO_0097232 | Cellular component | lamellar body membrane |
GO_0005770 | Cellular component | late endosome |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0097233 | Cellular component | alveolar lamellar body membrane |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0140345 | Molecular function | phosphatidylcholine flippase activity |
GO_0008559 | Molecular function | ABC-type xenobiotic transporter activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005319 | Molecular function | lipid transporter activity |
GO_0042626 | Molecular function | ATPase-coupled transmembrane transporter activity |
GO_0120019 | Molecular function | phosphatidylcholine transfer activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | ABCA3 |
Protein name | ABCA3 variant protein Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form] ATP-binding cassette, sub-family A (ABC1), member 3 ATP binding cassette subfamily A member 3 |
Synonyms | ABC3 protein variant |
Description | FUNCTION: Catalyzes the ATP-dependent transport of phospholipids such as phosphatidylcholine and phosphoglycerol from the cytoplasm into the lumen side of lamellar bodies, in turn participates in the lamellar bodies biogenesis and homeostasis of pulmonary surfactant . Transports preferentially phosphatidylcholine containing short acyl chains . In addition plays a role as an efflux transporter of miltefosine across macrophage membranes and free cholesterol (FC) through intralumenal vesicles by removing FC from the cell as a component of surfactant and protects cells from free cholesterol toxicity . . |
Accessions | Q99758 Q4LE27 H0Y3H2 ENST00000567910.1 [Q99758-2] ENST00000301732.10 [Q99758-1] A7MBM9 ENST00000382381.7 |